Fluorescent probes offer fuller view of drug delivery in cells

November 01, 2019

Selecting the most effective molecules for drug delivery is often a trial-and-error process, but Cornell engineers are providing some precision thanks to a technique that reveals the performance of those molecules inside living cells.

Drug delivery systems control the time and place therapeutics are released inside the body. An essential component of many drug delivery systems is the molecule that links an antibody - which seeks out a target such as cancer cells - to a drug designed to destroy the target. The linker must not only keep the drug tethered to the antibody as it travels to a targeted cell, it must properly release the drug inside the cell, in the right place at the right time.

Biomolecular engineers gather clues about linkers' effectiveness by testing them in cell-free environments - model fluids that don't contain all the complex interactions typically found in whole, living cells. They're easier to study, but aren't always as accurate, potentially leading to linker failure in subsequent testing.

A research team led by Chris Alabi, associate professor of chemical and biomolecular engineering, has developed a method that employs fluorescent probes to see and measure the rate at which linkers successfully release drugs in living cells. The research, "Responsive Antibody Conjugates Enable Quantitative Determination of Intracellular Bond Degradation Rate," published Oct. 8 in the journal Cell Chemical Biology.

"Right now, pharmaceutical companies make a ton of linkers and then see which functions best for a particular application by having to test each one. It's a shotgun approach," Alabi said. "With our technique, they can now make an informed decision based on actual intracellular numbers, before they put the drug system together."

The probes consist of two fluorescent dyes that render each other invisible when they're tethered together with the antibody as part of the delivery system. When the linker breaks and untethers the dyes, they become visible using a microscope, signaling the drug has been released inside the cell.

These probes were developed in Alabi's lab and offer engineers an accurate way to measure the rate at which a linker's chemical bond breaks from the delivery system while inside the cell.

"Once we know what the timing is for different linker bonds and cell processes, then we can say, 'OK, for drug A connected to antibody B, this is how long it will take, so if we want to treat disease C, we should use this linker,'" Alabi said.

To demonstrate the probe, Alabi and his team engineered an antibody construct with a disulfide linker known to work well within the HER2 protein, a highly valued target for breast cancer treatment. Once the delivery system reached the protein, the team was able to reliably measure intracellular processes, such as the kinetics and half-life of the disulfide linker.

"For the biomolecular engineers and companies that have a target in mind, we can ... make the drug discovery process that much faster because we now know something about how long it's going to take to release the drug," said Alabi, who hopes to demonstrate the technique further through partnerships with pharmaceutical companies.

The probes can also be used by chemical biologists to learn more about intracellular processes, such as the specific agents responsible for cleaving linkers, Alabi said.
The work was supported by funds from Cornell and the Nancy and Peter Meinig Investigator Fellowship.

Cornell University

Related Drug Delivery Articles from Brightsurf:

Modelling microswimmers for drug delivery
An international group of theoretical physicists led by Abdallah Daddi-Moussa-Ider from Düsseldorf, Germany, has modelled the motion of microscopic, motile bodies - either powered micro-machines or living cells - in viscous liquid drops, using the Navier-Stokes equations.

Millimetre-precision drug delivery to the brain
Focused ultrasound waves help ETH researchers to deliver drugs to the brain with pinpoint accuracy, in other words only to where their effect is desired.

New smart drug delivery system may help treatment for neurological disorders
A Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.

Novel drug delivery particles use neurotransmitters as a 'passport' into the brain
Drug-carrying lipid nanoparticles were created that incorporate neurotranmitters to help them cross the blood-brain barrier in mice.

Advances in nanoparticles as anticancer drug delivery vector: Need of this century
This review article provides a summary of current advances in the use of nanoparticles (NPs) as anticancer drug-delivery vectors.

Microcapsules for targeted drug delivery to cancer cells
A team of scientists from Peter the Great St. Petersburg Polytechnic University together with their colleagues developed a method of targeted drug delivery to cancer cells.

Improving drug delivery for brain tumor treatment
Despite improvements in drug delivery mechanisms, treating brain tumors has remained challenging.

Nanoparticle orientation offers a way to enhance drug delivery
MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling an inherent trait of chemical structures, known as chirality -- the 'handedness' of the structure.

News about drug delivery
Nanocontainer for drugs can have their pitfalls: If they are too heavily loaded, they will only dissolve poorly.

Deflating beach balls and drug delivery
Gwennou Coupier and his colleagues at Grenoble Alps University, Grenoble, France have shown that macroscopic-level models of the properties of microscopic hollow spheres agree very well with theoretical predictions.

Read More: Drug Delivery News and Drug Delivery Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.